PBM Reform Delays Continue to Negatively Impact Pharmacies | AAP 2025
Drug Topics
APRIL 10, 2025
A conversation with Douglas Hoey, CEO of the National Community Pharmacists Association, at the American Associated Pharmacies 2025 Annual Conference.
Thu.Apr 10, 2025
624 
Opinion: The wellness industry is killing animals, spreading disease, and fueling the next pandemic
STAT
APRIL 10, 2025
The $6.3 trillion wellness industry thrives on distrust of science, glorifying “natural” alternatives, and fear-based marketing. The result? Pseudoscience that’s not just harming human health. It’s killing animals, too, specifically via H5N1 bird flu. Holistic pet health influencers, organic farmers, and alternative medicine advocates embrace behaviors that increase the risk of viral transmission, paving the way for a potential human pandemic.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Cost-Effectiveness of PCV15, 20 Vaccines Expected to Decrease
Drug Topics
APRIL 10, 2025
Using a cost-utility analysis, researchers addressed the cost-effectiveness of pneumococcal vaccine strategies for adults over the age of 64.
Opinion: The National Cancer Institute’s Investigational New Drug program is imperative for public good
STAT
APRIL 10, 2025
Mark Ratain’s First Opinion piece of Feb. 4, 2025 , implies that the oncologists in NCI’s Investigational Drug Branch (IDB) colluded with the drug company Exilixis to sponsor two Phase 3 studies of its drug cabozantanib. He claims these studies showed minimal benefit, yet the results were used to inflate the value of Exilixis stock. Ratain concludes by recommending that IDB be abolished.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Data Show Neural Mechanisms Between Obesity and Cognition
Drug Topics
APRIL 10, 2025
Investigators find 5 distinct obesity trajectories that influenced brain morphology, function, and cognition.
West Middlesex Hospital goes live with tech to reduce prescribing errors
Pharmafile
APRIL 10, 2025
Dosium Touchdose has gone live at West Middlesex University Hospital, UK, a clinical decision support technology proven to significantly reduce prescribing errors. This follows go-live at both Chelsea and Westminster Hospital last month, and St Marys Hospital last summer, marking the final stage of rollout across the entire West London Childrens Healthcare (WLCH) partnership.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: Gilead is urged to rework licensing deals for groundbreaking HIV prevention drug
STAT
APRIL 10, 2025
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences should issue compulsory licenses if the company fails to modify an existing licensing program with half a dozen generic makers. In an essay in Clinical Infectious Diseases , they complained Gilead pursued voluntary licenses that are too restrictive, which will delay or deny access to its drug.
The Rise in Direct-to-Consumer Advertising of Prescription Drugs
Drug Topics
APRIL 10, 2025
Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.
3 foods to avoid while taking Strattera
The Checkup by Singlecare
APRIL 10, 2025
Strattera (atomoxetine) is a brand name, non-stimulant drug approved by the U.S. Food and Drug Administration (FDA) to treat attention deficit hyperactivity disorder (ADHD). Its also prescribed off-label for other medical conditions, such as treating a specific type of low blood pressure called neurogenic orthostatic hypotension and reducing symptoms of major depressive disorder in people who also have ADHD.
Persistent Statin Use Shows Increase of Risk Diabetes for Obstructive Sleep Apnea, Hypertension Patients
Drug Topics
APRIL 10, 2025
Hypertension and obstructive sleep apnea are considered independent risk factors for cardiovascular diseases as well as diabetes.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
CDC officials plan for the agency’s splintering, but questions remain
STAT
APRIL 10, 2025
NEW YORK — A top Centers for Disease Control and Prevention official told staff this week to start planning for the agency’s splintering. Several parts of CDC — mostly those devoted to health threats that aren’t infectious — are being spun off into the soon-to-be-created Administration for a Healthy America, the agency official told senior leaders in calls and meetings.
At-Home Testing: How Can Pharmacy Play a Role?
Drug Topics
APRIL 10, 2025
Jenna Anderson, CEO of KiHealth Inc, and Amanda Wiley, marketing manager of HealthSource Marketing, discuss the evolving role of pharmacies in at-home testing.
Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months
Pharmafile
APRIL 10, 2025
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over a period of at least 18 months. If approved by regulators, HMTM could be the first oral treatment for the disease that targets the tau protein. Conventionally, targeted therapies for Alzheimers focused on amyloid protein […] The post Research finds tablet effective in slowing progression of Alzheimers disease over 18 months appeared f
Transform Your Pharmacy into a Thriving Community Health Hub
Drug Topics
APRIL 10, 2025
Ashley Keller, CPhT, hosted a session at the Total Pharmacy Solutions Summit Spring 2025 exploring the services and strategies community pharmacies can employ to make their businesses thrive.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
When middlemen own it all, patients pay the price
PhRMA
APRIL 10, 2025
These days, the same big health care conglomerate could own your PBM, insurer, pharmacy and even your doctor’s office. Middlemen now control what medicines you can get, what you pay at the pharmacy counter, what pharmacy you can you use and what hoops you must jump through to get the medicine your doctor prescribed.
Pharmacy Management Must Consider Needs of Employees
Drug Topics
APRIL 10, 2025
Female pharmacists make up approximately 62% of the pharmacy workforce. They want, and in many cases demand, a good work-life balance.
New insights on blister-packaged oral oncolytic agents for adherence
Hospital Pharmacy Europe
APRIL 10, 2025
Non-adherence can negatively impact medication treatment strategies, particularly among oncology patients, driving up treatment costs while potentially worsening clinical outcomes. Although oral oncolytics offer convenience, they arguably require greater patient engagement in remembering to take their treatment, often resulting in lower adherence compared to infused therapies.
Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers
European Pharmaceutical Review
APRIL 10, 2025
There is worldwide concern around the use of PFAS. In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
A pharmacist-led medicines optimisation and adherence tool for geriatric oncology
Hospital Pharmacy Europe
APRIL 10, 2025
A tool to streamline hospital outpatient clinics for geriatric oncology patients has been developed by a clinical pharmacist and clinical nurse specialist at the Royal Marsden NHS Foundation Trust. The eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool facilitates integrated care by remotely assessing medications, nutrition, social support, mood, and functional status, enhancing clinical efficiency and patient outcomes.
AAX Biotech aims to enhance growth with two new appointments
Pharmafile
APRIL 10, 2025
AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, contributing to its strategy to develop its research and business. The company experiences growing interest in its Seqitope and Opti-mAb technologies, platforms pioneering its mission to develop innovative antibody therapeutics.
US government appeals after judge blocks NIH funding cap
pharmaphorum
APRIL 10, 2025
HHS has said it plans to appeal a permanent injunction on big cuts to indirect funding for medical research awarded by the NIH.
FDA Clears Dexcom G7 15 Day, Marking the Longest-Lasting CGM System
Pharmacy Times
APRIL 10, 2025
Data show that the system is also the most accurate continuous glucose monitor (CGM).
At-home tablet now an option for NHS bladder cancer patients
pharmaphorum
APRIL 10, 2025
The first targeted drug for a common form of bladder cancer that can be taken at home.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 10, 2025
More than two dozen healthcare associations are worried healthcare is on the wrong trajectory, as the aftermath of the reductions in force at HHS become clearer.
FDA Approves Larotrectinib for Adult and Pediatric Patients With NTRK Gene Fusion-Positive Solid Tumors
Pharmacy Times
APRIL 10, 2025
The approval is for those with metastatic disease or in whom surgical resection is likely to result in severe morbidity, have no satisfactory alternative treatments, or have progressed following treatment.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 10, 2025
Recent executive actions aim to slash regulations the administration considers unlawful or anticompetitive. Under one order giving broad discretion to agencies, healthcare could start seeing the impacts as soon as April 19.
Hold the Joint, the Federal Marijuana Movement Just Hit the Brakes
Pharmacy Times
APRIL 10, 2025
Many other issues on the new administrations plate are taking priority.
Cheaper Soliris biosimilars reach the US market
pharmaphorum
APRIL 10, 2025
The first biosimilars of AstraZeneca/Alexion's blockbuster complement C5 inhibitor Soliris have been launched in the US at a discount to the brand
HOPA 2025: Insights Into Post-Transplant Cyclophosphamide Use for Graft-Versus-Host Disease Prevention
Pharmacy Times
APRIL 10, 2025
Lauren Dietz, PharmD, highlighted the role of oncology pharmacists in guiding prophylaxis decisions to optimize transplant outcomes.
Healthcare Scorecard from Patients with Chronic Illness
Pharmaceutical Commerce
APRIL 10, 2025
A look at the prevailing factors impacting treatment access in 2025.
The Evolving Pharmacist Role in HER2-Negative Adjuvant Breast Cancer Therapy
Pharmacy Times
APRIL 10, 2025
Julia Ziegengeist, PharmD, BCOP offers insights for pharmacists navigating adjuvant and neoadjuvant treatment of breast cancer.
EVERSANA adds AI to medical, legal and regulatory reviews
pharmaphorum
APRIL 10, 2025
A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
Pharmacy Times
APRIL 10, 2025
Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.
Let's personalize your content